Biolase Technology, Inc. (BIOL) Posts Q1 Loss of 11c/Share

Biolase Technology, Inc. (NASDAQ: BIOL) reported Q1 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $13.29 million.

For earnings history and earnings-related data on Biolase Technology, Inc. (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Reading (RDI) Tops Q2 EPS by 4c